Chemical activators of the protein "Or1e34" engage in a multifaceted mechanism aimed at influencing its activity. Among these activators, Resveratrol plays a pivotal role by acting on the Sirtuin pathway. This compound can activate Sirtuins, a class of deacetylases, which, in turn, can deacetylate specific target proteins. In the context of "Or1e34," the deacetylation of certain regulatory elements can lead to enhanced gene expression and function. Similarly, Forskolin exerts its impact through adenylate cyclase activation, resulting in elevated cyclic AMP (cAMP) levels. The increased cAMP can stimulate downstream signaling pathways, indirectly affecting the regulation of "Or1e34" by modulating its cellular environment. LY294002 takes a different approach by inhibiting the PI3K pathway, which can indirectly influence the "Or1e34" gene's activity. This inhibition alters the balance of signaling events in the cell, potentially leading to changes in the transcriptional regulation of "Or1e34." Furthermore, SB203580 intervenes by targeting p38 MAPK, which is intricately connected to various cellular processes, including gene expression. The modulation of p38 MAPK may indirectly impact the "Or1e34" gene's regulation, highlighting the complexity of the interplay between these chemicals and the protein's activity.
JAK Inhibitor I stands as a noteworthy activator, as it influences the JAK/STAT pathway, known to be associated with "Or1e34." By modulating this pathway, JAK Inhibitor I can potentially enhance the transcriptional regulation of the gene. Additionally, XAV939 actively participates by inhibiting the Wnt pathway, which can indirectly affect the activity of "Or1e34" through downstream signaling events. Bay 11-7082 takes on a unique role by inhibiting NF-κB activation. Its modulation can influence the regulation of "Or1e34" by altering the cellular response to inflammatory stimuli. DAPT targets the Notch signaling pathway, which has been linked to certain aspects of "Or1e34" regulation. Through the inhibition of Notch, DAPT can indirectly impact the gene's expression and function. Similarly, SB431542 intervenes by inhibiting the TGF-β receptor, potentially affecting the "Or1e34" gene's function by disrupting TGF-β signaling. GDC-0449 is instrumental as it antagonizes the Hedgehog pathway, which may have downstream effects on the "Or1e34" gene, considering its involvement in various cellular processes. In summary, these chemicals, by engaging with specific signaling pathways, can indirectly activate the "Or1e34" gene, impacting its transcriptional regulation and functional activation.
더보기
Items 1 to 10 of 12 total
디스플레이 라벨:
제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
레스베라트롤은 시르투인 경로에 영향을 미치는 것으로 알려져 있으며, 이는 "Or1e34" 유전자의 활성에 간접적으로 영향을 줄 수 있습니다. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
포스콜린은 아데닐레이트 시클라제를 활성화하여 "Or1e34"의 조절에 영향을 줄 수 있는 cAMP 수치를 증가시킬 수 있습니다. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002는 PI3K 경로를 억제하며, 이 경로의 억제는 Or1e34 유전자의 활성에 간접적으로 영향을 미칠 수 있습니다. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $30.00 $125.00 $445.00 | 45 | |
SB203580은 p38 MAPK의 억제제이며, 그 조절은 "Or1e34"의 조절에 다운스트림 영향을 미칠 수 있습니다. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $153.00 $332.00 | 59 | |
이 JAK 억제제는 Or1e34 유전자와 관련된 JAK/STAT 경로에 잠재적으로 영향을 미칠 수 있습니다. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
XAV939는 Wnt 경로의 저분자 억제제로, Or1e34의 활동에 간접적으로 영향을 미칠 수 있습니다. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
베이 11-7082는 NF-κB 활성화를 억제하며, 그 조절은 Or1e34 유전자의 조절에 영향을 미칠 수 있습니다. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
DAPT는 "Or1e34" 조절의 특정 측면과 연관된 Notch 신호 경로를 억제합니다. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542는 TGF-β 수용체 억제제로, 그 조절이 Or1e34 유전자의 기능에 간접적으로 영향을 미칠 수 있습니다. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $80.00 $96.00 | 1 | |
비스모데깁은 고슴도치 경로의 길항제로서 Or1e34 유전자에 하류 영향을 미칠 수 있습니다. |